Abstract
Thrombocytopenia is a common complication of chronic liver diseases, but its pathogenesis is not clear. Although generally attributed to hypersplenism, other factors should also be considered. We investigated the relationship between the peripheral platelet count and the degree of fibrosis in patients with chronic viral hepatitis. In an effort to avoid the effects of hypersplenism, we excluded patients with splenomegaly and/or bi- or pan-cytopenia. Seven hundred eighty-four patients (265 chronic viral hepatitis C and 519 chronic viral hepatitis B) were included in the study. Univariate analysis showed that the peripheral platelet count had a negative correlation with fibrosis score, necroinflammatory activity, and age in both groups. In multivariate analysis, the peripheral platelet count had a similar correlation with the fibrosis score and age, but not with necroinflammatory activity, in both groups. The peripheral platelet count decreased more significantly in females with chronic hepatitis C but not in the chronic hepatitis B group. In conclusion, a decrease in peripheral platelet count may be a sign of an increase in the degree of fibrosis during the course of chronic viral hepatitis B and C and factors other than hypersplenism may play a role in this decrease in the peripheral platelet count.
Similar content being viewed by others
References
Morlock CG, Hall BE (1943) Association of cirrhosis, thrombocytopenia and hemorrhagic tendency. Arch Intern Med 72:69–77
Felix WR Jr, Myerson RM, Sigel B, Perrin EB, Jackson FC (1974) The effect of portacaval shunt on hypersplenism. Surg Gynecol Obstet 139:899–903
Soper NJ, Rikkers LF (1982) Effect of operations for variceal hemorrhage on hypersplenism. Am J Surg 144:70
Morris PW, Patton TB, Balint JA, Hirschowitz BI (1962) Portal hypertension, congestive splenomegaly, and portacaval shunt. Gastroenterology 42:555–559
Mutchnick MG, Lerner E, Conn HO (1980) Effect of portacaval anastamosis on hypersplenism. Dig Dis Sci 25:929–938
Hutson DG, Zeppa R, Levi JU, Schiff ER, Livingstone AS, Fink P (1977) The effect of the distal splenorenal shunt on hypersplenism. Ann Surg 185:605–612
Frick V (1967) Thrombocytopenie und lebercirrhose. Scweiz Med Wochens 97:407–413
Fiore LD, Brophy MT, Deykin D (2003) Hemostasis. In: Zackim D, Boyer TD (eds) Hepatology: A textbook of liver disease. 4th edn. pp 562–563
Omata M (1998) Screening for hepatocellular carcinoma. In: Advances in therapeutic hepatology: A word view. Postgraduate course book. University of Chicago Press, Chicago, pp. 49–53
Moschcowitz E (1948) The pathogenesis of splenomegaly in hypertension of the portal circulation: “congestive splenomegaly.” Medicine 27:187–221
Landolfi R, Leone G, Fedeli G, Storti S, Laghi F, Bizzi B (1980) Platelet-associated IgG in acute and chronic hepatic diseases. Scand J Haematol 25:417–422
de Noronha R, Taylor BA, Wild G, Triger DR, Greaves M (1991) Interrelationships between platelet count, platelet IgG, serum IgG, immune-complexes and severity of liver disease. Clin Lab Haematol 13:127–135
Skootsky SA, Rosove MH, Langley MB (1986) Immune thrombocytopenia and response to splenectomy in chronic liver disease. Arch Intern Med 146:555–557
Paramo JA, Rocha E (1993) Hemostasis in advanced liver disease. Semin Thromb Hemost 19:184–190
Wehmeier A, Scharf RE, Schneider W (1990) Influence of splenectomy on platelet morphometry and function. Klin Wochenschr 68:847–852
Thomas HC, McSween RN, White RG (1973) Role of the liver in controlling the immunogenicity of commensal bacteria in the gut. Lancet 1:1288–1291
Triger DR, Wright R (1973) Hyperglobulinaemia in liver disease. Lancet 1:1494–1496
Kew MC (1996) Hepatitis B and C viruses and hepatocellular carcinoma. Clin Lab Med 16:395–406
MacPherson AI, Innes J (1953) Peripheral blood picture after operation for portal hypertension. Lancet 1:1120–1123
Vang J, Simert G, Hansson JA, Thylen U, Bengmark TS (1977) Results of a modified distal spleno–renal shunt for portal hypertension. Ann Surg 185:224–228
Sullivan BH Jr, Tumen HJ (1961) The effect of portacaval shunt on thrombocytopenia associated with portal hypertension. Ann Intern Med 55:598–603
Karasu Z, Gurakar A, Kerwin B, Hulagu S, Jazzar A, McFadden R, Nour B, Sebastian A, Cassidy F, Stokes K, Van Thiel DH, Wright H (2000) Effect of transjugular intrahepatic portosystemic shunt on thrombocytopenia associated with cirrhosis. Dig Dis Sci 45:1971–1976.
Patton TB, Johnston CG, Lyons C, Jordan P Jr (1959) Lateral portacaval anastomosis for portal hypertension: long term results in 58 patients with intrahepatic portal bed block and 7 patients with extrahepatic portal bed block. Am J Gastroenterol 32:291–310
Puttini M, Marni A, Montes F, Belli L (1979) Effect of portasystemic shunt on hypersplenism: Clinical study in 129 patients with cirrhosis. Am Surg 45:444–448
Ferrara J, Ellison EC, Martin EW Jr, Cooperman M (1979) Correction of hypersplenism following distal splenorenal shunt. Surgery 86:570–573
Malt RA (1976) Portasystemic venous shunts (part 1). N Engl J Med 295:24–29
Marni A, Trojsi C, Belli L (1981) Distal splenorenal shunt. Hemodynamic advantage over total shunt and influence on clinical status, hepatic function and hypersplenism. Am J Surg 142:372–376
LaBerge JM, Ring EJ, Gordon RL, Lake JR, Doherty MM, Somberg KA, Roberts JP, Ascher NL (1993) Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients. Radiology 187:413–420
Lawrence SP, Lezotte DC, Durham JD, Kumpe DA, Everson GT, Bilir BM (1995) Course of thrombocytopenia of chronic liver disease after transjugular intrahepatic portosystemic shunts (TIPS). A retrospective analysis. Dig Dis Sci 40:1575–1580
Alvarez OA, Lopera GA, Patel V, Encarnacion CE, Palmaz JC, Lee M (1996) Improvement of thrombocytopenia due to hypersplenism after transjugular intrahepatic portosystemic shunt placement in cirrhotic patients. Am J Gastroenterol 91:134–137
Sungaran R, Markovic B, Chong BH (1997) Localization and regulation of thrombopoietin mRNA expression in human kidney, liver, bone marrow and spleen using in situ hybridization. Blood 89:101–107
Martin TG 3rd, Somberg KA, Meng YG, Cohen RL, Heid CA, de Sauvage FJ, Shuman MA (1997) Thrombopoietin levels in patients with cirrhosis before and after orthotopic liver transplantation. Ann Intern Med 127:285–288
Peck-Radosavljevic M, Zacherl J, Meng YG, Pidlich J, Lipinski E, Langle F, Steininger R, Muhlbacher F, Gangl A (1997) Is inadequate thrombopoietin production a major cause of thrombocytopenia in cirrhosis of the liver? J Hepatol 27:127–131
Ishikawa T, Ichida T, Matsuda Y, Sugitani S, Sugiyama M, Kato T, Miyazaki H, Asakura H (1998) Reduced expression of thrombopoietin is involved in thrombocytopenia in human and rat liver cirrhosis. J Gastroenterol Hepatol 13:907–913
Stiegler G, Stohlawetz P, Peck-Radosavljevic M, Jilma B, Pidlich J, Wichlas M, Hocker P, Panzer S (1998) Direct evidence for an increase in thrombopoiesis after liver transplantation. Eur J Clin Invest 28:755–759
Yanaga K, Tzakis AG, Shimada M, Campbell WE, Marsh JW, Stieber AC, Makowka L, Todo S, Gordon RD, Iwatsuki S (1989) Reversal of hypersplenism following orthotopic liver transplantation. Ann Surg 210:180–183
Hutchison DE, Genton E, Porter KA, Daloze PM, Huguet C, Brettschneider L, Groth CG, Starzl TE (1968) Platelet changes following clinical and experimental hepatic homotransplantation. Arch Surg 97:27–33
Rinkes IH, Van der Hoop AG, Hesselink EJ, Metselaar H, De Rave S, Zonderland HM, Schalm SW, Terpstra OT (1991) Does auxiliary heterotopic liver transplantation reverse hypersplenism and portal hypertension? Gastroenterology 100:1126–1128
Ono E, Shiratori Y, Okudaira T, Imamura M, Teratani T, Kanai F, Kato N, Yoshida Y, Shiina S, Omata M (1999) Platelet count reflects stage of chronic hepatitis C. Hepatol Res 15:192–200
Matsumuro H, Moriyama M, Goto I, Tanaka N, Okubo H, Arakawa Y (2000) Natural course of progression of liver fibrosis in Japanese patients with chronic liver disease type C—a study of 527 patients at one establishment. J Viral Hepat 7:268–275
Okubo M, Shiota G, Kawasaki H (2000) Thrombopoietin levels in serum and liver tissue in patients with chronic viral hepatitis and hepatocellular carcinoma. Clin Sci (Lond) 99:207–214
Pohl A, Behling C, Oliver D, Kilani M, Monson P, Hassanein T (2001) Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection. Am J Gastroenterol 96:3142–3146
Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J (1981) Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431–435
Fusegawa H, Shiraishi K, Ogasawara F, Shimizu M, Haruki Y, Miyachi H, Matsuzaki S, Ando Y (2002) Platelet activation in patients with chronic hepatitis C. Tokai J Exp Clin Med 27:101–106
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Karasu, Z., Tekin, F., Ersoz, G. et al. Liver Fibrosis Is Associated with Decreased Peripheral Platelet Count in Patients with Chronic Hepatitis B and C. Dig Dis Sci 52, 1535–1539 (2007). https://doi.org/10.1007/s10620-006-9144-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-006-9144-y